AMPK - A pivotal rheostat in the control of cardiac metabolism

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 1, 2005, Pages 93-100

  Miller, Edward J ^a   Russell, Raymond R ^a   Li, Ji ^a   Young, Lawrence H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE TRIPHOSPHATE; ADIPONECTIN; ANTIDIABETIC AGENT; CASPASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LIPOPROTEIN LIPASE; METFORMIN;

APOPTOSIS; ENERGY CONSUMPTION; ENZYME ACTIVATION; ENZYME INHIBITION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN METABOLISM; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 33645047157     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.05.008     Document Type: Review

References (57)

1. L. Opie G.D. Lopaschuk Fuels: Aerobic and anaerobic metabolism L. Opie Heart Physiology: From Cell to Circulation 4th edn 2004 Lippincott Williams & Wilkins Philadelphia, PA 307-354
2. L.H. Young et. al. Cellular and molecular regulation of cardiac glucose transport J. Nucl. Cardiol. 7 2000 267-276
3. R.R. Russell III et. al. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR Am. J. Physiol. 277 1999 H643-H649
4. N. Kudo et. al. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase J. Biol. Chem. 270 1995 17513-17520
5. R.R. Russell III et. al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J. Clin. Invest. 114 2004 495-503
6. N.B. Ruderman et. al. Malonyl-CoA and AMP-activated protein kinase (AMPK): Possible links between insulin resistance in muscle and early endothelial cell damage in diabetes Biochem. Soc. Trans. 31 2003 202-206
7. D.G. Hardie The AMP-activated protein kinase pathway - new players upstream and downstream J. Cell Sci. 117 2004 5479-5487
8. T.J. Iseli et. al. AMP-activated protein kinase {beta} subunit tethers {alpha} and {gamma} subunits via its C-terminal sequence (186-270) J. Biol. Chem. 280 2005 13395-13400
9. D.L. Coven et. al. Physiological role of AMP-activated protein kinase in the heart: Graded activation during exercise Am. J. Physiol. Endocrinol. Metab. 285 2003 E629-E636
10. L.G. Fryer et. al. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J. Biol. Chem. 277 2002 25226-25232
11. S.P. Davies et. al. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC FEBS Lett. 377 1995 421-425
12. M.Y. Wang R.H. Unger Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone Am. J. Physiol. Endocrinol. Metab. 288 2005 E216-E221
13. C. Beauloye et. al. Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides FEBS Lett. 505 2001 348-352
14. S.J. Baron et. al. Dual mechanisms regulating AMPK kinase action in the ischemic heart Circ. Res. 96 2005 337-345
15. J.Y. Altarejos et. al. Myocardial ischemia differentially regulates LKB1 and an alternate 5′-AMP-activated protein kinase kinase J. Biol. Chem. 280 2005 183-190
16. A. Woods et. al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade Curr. Biol. 13 2003 2004-2008
17. S.A. Hawley et. al. Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade J. Biol. 2 2003 28
18. J.M. Lizcano et. al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1 EMBO J. 23 2004 833-843
19. M. Ponticos et. al. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle EMBO J. 17 1998 1688-1699
20. R. Rafaeloff-Phail et. al. Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH J. Biol. Chem. 279 2004 52934-52939
21. H. Clark et. al. Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids Eur. J. Biochem. 271 2004 2215-2224
22. Y. Minokoshi et. al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase Nature 415 2002 339-343
23. L.L. Atkinson et. al. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis J. Biol. Chem. 277 2002 29424-29430
24. E. Tomas et. al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation Proc. Natl. Acad. Sci. USA 99 2002 16309-16313
25. R. Shibata et. al. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling J. Biol. Chem. 279 2004 28670-28674
26. R. Shibata et. al. Adiponectin-mediated modulation of hypertrophic signals in the heart Nat. Med. 10 2004 1384-1389
27. L.H. Young et. al. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo Circulation 95 1997 415-422
28. R. Tian et. al. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy Circulation 104 2001 1664-1669
29. Y. Xing et. al. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase J. Biol. Chem. 278 2003 28372-28377
30. A. Pelletier et. al. AMPK and p38 MAPK participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes Endocrinology 2005
31. J. Li et. al. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle Am. J. Physiol. Endocrinol. Metab. 287 2004 E834-E841
32. A.S. Marsin et. al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia Curr. Biol. 10 2000 1247-1255
33. J.J. Luiken et. al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling Diabetes 52 2003 1627-1634
34. D. An et. al. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase Am. J. Physiol. Endocrinol. Metab. 288 2005 E246-E253
35. Z. Chen et. al. Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle FEBS Lett. 460 1999 343-348
36. D. Carling D.G. Hardie The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase Biochim. Biophys. Acta 1012 1989 81-86
37. B. Viollet et. al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity J. Clin. Invest. 111 2003 91-98
38. G. Polekhina et. al. AMPK beta subunit targets metabolic stress sensing to glycogen Curr. Biol. 13 2003 867-871
39. M.E. Young et. al. Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR - an activator of AMP-activated protein kinase FEBS Lett. 382 1996 43-47
40. J. Shang M.A. Lehrman Activation of glycogen phosphorylase with 5-aminoimidazole-4-carboxamide riboside (AICAR). Assessment of glycogen as a precursor of mannosyl residues in glycoconjugates J. Biol. Chem. 279 2004 12076-12080
41. D. Milan et. al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle Science 288 2000 1248-1251
42. J. Hedegaard et. al. UDP-glucose pyrophosphorylase is upregulated in carriers of the porcine RN- mutation in the AMP-activated protein kinase Proteomics 4 2004 2448-2454
43. M.H. Gollob et. al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy Circulation 104 2001 3030-3033
44. J. Mu et. al. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle Mol. Cell 7 2001 1085-1094
45. B.F. Holmes et. al. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle J. Appl. Physiol. 87 1999 1990-1995
46. M. Arad et. al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy Circulation 107 2003 2850-2856
47. J.S. Sidhu et. al. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome Circulation 111 2005 21-29
48. A. Tsuchida et. al. Acadesine extends the window of protection afforded by ischaemic preconditioning Cardiovasc. Res. 28 1994 379-383
49. B. Burckhartt et. al. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits Cardiovasc. Res. 29 1995 653-657
50. C. Peralta et. al. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat Hepatology 34 2001 1164-1173
51. G.D. Lopaschuk Metabolic abnormalities in the diabetic heart Heart Fail. Rev. 7 2002 149-159
52. H. Taegtmeyer Energy metabolism of the heart: From basic concepts to clinical applications Curr. Probl. Cardiol. 19 1994 59-113
53. L.H. Young et. al. Regulation of myocardial glucose uptake and transport during ischemia and energetic stress Am. J. Cardiol. 83 1999 25H-30H
54. B. Charbonnel et. al. The prospective pioglitazone clinical trial in macrovascular events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients Diabetes Care 27 2004 1647-1653
55. D.T. Mangano Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group JAMA 277 1997 325-332
56. P.E. Light et. al. Constitutively active adenosine monophosphate-activated protein kinase regulates voltage-gated sodium channels in ventricular myocytes Circulation 107 2003 1962-1965
57. Y. Nishino et. al. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection Cardiovasc. Res. 61 2004 610-619